Location History:
- Nashua, NH (US) (1982)
- Haverhill, MA (US) (1982 - 1984)
Company Filing History:
5 out of 224 
3 out of 3 
1 out of 8 Years Active: 1982-1984
Title: David R. Crockford: Innovator in Cancer Detection Technologies
Introduction
David R. Crockford is a notable inventor based in Haverhill, MA (US), recognized for his significant contributions to cancer detection technologies. With a total of 5 patents, his work has advanced the field of medical diagnostics, particularly in the detection of tumors through innovative methods.
Latest Patents
Crockford's latest patents focus on compositions and methods for detecting cancer using technetium-labeled antibody fragments. One of his key inventions involves the use of F(ab').sub.2 or Fab fragments of antibodies that target specific tumor-associated molecules, such as human chorionic gonadotropin (hCG) and carcinoembryonic antigen (CEA). When these radiolabeled fragments are injected into a patient, they accumulate at tumor sites, allowing for detection through external gamma scintigraphy. This method enhances the monitoring and localization of cancer, providing a semi-noninvasive technique for tumor detection.
Career Highlights
Throughout his career, Crockford has worked with various organizations, including University Patents, Inc. and Nuc Med Inc. His innovative approaches have contributed to the development of advanced diagnostic tools that improve cancer detection and patient outcomes.
Collaborations
Crockford has collaborated with notable professionals in the field, including Buck A. Rhodes and Scott W. Burchiel. These partnerships have fostered the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
David R. Crockford's work in cancer detection technologies exemplifies the importance of innovation in medical diagnostics. His patents and collaborations have paved the way for advancements that can significantly improve the early detection and treatment of cancer.